Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder
This study has been completed.
Information provided by:
First received: April 27, 2007
Last updated: NA
Last verified: April 2007
History: No changes posted
The purpose of the study is to investigate if NS2359 is effective in the treatment of ADHD in adult patients.
Attention Deficit Hyperactivity Disorder
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder. A Randomised, Double-Blind, Placebo-Controlled Study|
Resource links provided by NLM:
Further study details as provided by NeuroSearch A/S:
Primary Outcome Measures:
- To investigate the efficacy of NS2359 in adult patients diagnosed with ADHD (predominantly inattentive, predominantly hyperactive/impulsive or combined) according to DSM-IV criteria.
Secondary Outcome Measures:
- To investigate the safety and tolerability of NS2359 in adult ADHD patients.
|Study Start Date:||August 2003|
|Study Completion Date:||September 2004|
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00467428
|United States, Massachusetts|
|Adult and Pediatric Psychopharmacology, Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02114|
Sponsors and Collaborators
|Principal Investigator:||Thimothy Wilens, MD||Adult and Pediatric Psychopharmacology, Masschusetts General Hospial, Boston, US|